Unique ID issued by UMIN | UMIN000040954 |
---|---|
Receipt number | R000046766 |
Scientific Title | A prospective cohort study for evaluating the short-term outcomes of laparoscopic gastrectomy for advanced gastric cancer with preoperative chemotherapy |
Date of disclosure of the study information | 2020/07/01 |
Last modified on | 2020/06/30 11:21:22 |
A prospective cohort study for evaluating the short-term outcomes of laparoscopic gastrectomy for advanced gastric cancer with preoperative chemotherapy
A prospective cohort study of laparoscopic gastrectomy for advanced gastric cancer with preoperative chemotherapy
A prospective cohort study for evaluating the short-term outcomes of laparoscopic gastrectomy for advanced gastric cancer with preoperative chemotherapy
A prospective cohort study of laparoscopic gastrectomy for advanced gastric cancer with preoperative chemotherapy
Japan |
Advanced gastric cancer with preoperative chemotherapy
Gastrointestinal surgery |
Malignancy
NO
To evaluate the short-term outcomes of laparoscopic gastrectomy for advanced gastric cancer with preoperative chemotherapy
Safety
Phase II
Incidence of anastomotic leakage greater than Grade 2 and pancreatic fistula greater than Grade 3 according to Clavien-Dindo classification
1. Rate of curative resection (R0, R1), 2.
Overall survival, 3. Relapse-free survival, 4. Completion rate of laparoscopic surgery, 5. Rate of conversion to open surgery, 6. Intraoperative complications, 7. Postoperative complications, 8. Surgery-related death within 30 days, 9. In-hospital mortality, 10. Postoperative course, 11. Patterns of recurrence
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Maneuver |
Laparoscopic gastrectomy
20 | years-old | <= |
85 | years-old | >= |
Male and Female
1) Histologically proven gastric adenocarcinoma
2) Clinical Stage III or Stage IV gastric cancer curably treated with total, proximal, or distal gastrectomy after preoperative chemotherapy
3) ECOG performance status of 0 or 1
4) Informed consent is obtained
1) With active double or multiple cancers
2) Severe complications
3) With active infection
4) Past history of severe hypersensitivity to drugs
5) Patients judged inappropriate for the study by the physicians
70
1st name | Masafumi |
Middle name | |
Last name | Inomata |
Oita University Faculty of Medicine
Department of Gastroenterological and Pediatric Surgery
879-5593
1-1, Hasamamachi, Yufu City, Oita
097-586-5843
inomata@oita-u.ac.jp
1st name | Tsuyoshi |
Middle name | |
Last name | Etoh |
Oita University Faculty of Medicine
Department of Gastroenterological and Pediatric Surgery
879-5593
1-1, Hasamamachi, Yufu City, Oita
097-586-5843
teto@oita-u.ac.jp
Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine
Self funding
Self funding
General Clinical Research Center, Oita University Hospital
1-1, Hasamamachi, Yufu City, Oita
097-586-6163
gcrc-oita@oita-u.ac.jp
NO
2020 | Year | 07 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2020 | Year | 05 | Month | 21 | Day |
2020 | Year | 05 | Month | 21 | Day |
2020 | Year | 05 | Month | 21 | Day |
2025 | Year | 05 | Month | 31 | Day |
2025 | Year | 05 | Month | 31 | Day |
2025 | Year | 05 | Month | 31 | Day |
2026 | Year | 12 | Month | 31 | Day |
2020 | Year | 06 | Month | 30 | Day |
2020 | Year | 06 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046766